Global Trials Focus
[vc_row][vc_column][vc_column_text]Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world.
Highlight:
- SGLT-2 inhibition strikes again
Dapagliflozin in Patients with Chronic Kidney Disease
See the latest trials here.
A summary of the highlighted trial is now available in French, Mandarin, and Spanish.
Support equal access to nephrology research: Become an ISN Member![/vc_column_text][/vc_column][/vc_row]